Coupling in vitro and in vivo paradigm reveals a dose dependent inhibition of angiogenesis followed by initiation of autophagy by C6-ceramide

International Journal of Biological Sciences

Volumn 7, Issue 5, 2011, Pages 629-644

  Bansode, Rishipal R ^a   Ahmedna, Mohamed ^a   Svoboda, Kurt R ^b   Losso, Jack N ^b  

^a North Carolina Research Campus   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Apoptosis; Autophagy; Ceramide; MCF 7 cell line; VEGF; Zebrafish

Indexed keywords

DANIO RERIO;

EID: 79960132625     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7.629     Document Type: Article

References (51)

1. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004; 4(8): 604-16.
2. Lemonnier LA, Dillehay DL, Vespremi MJ, et al. Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch Biochem Biophys. 2003; 419(2): 129-38.
3. Struckhoff AP, Bittman R, Burow ME, et al. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer. J Pharmacol Exp Ther. 2004; 309(2): 523-32.
4. Cai Z, Bettaieb A, Mahdani NE, et al. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity. J Biol Chem. 1997; 272(11): 6918-26.
5. Radin NS. Killing tumours by ceramide-induced apoptosis: a critique of available drugs. Biochem J. 2003; 371(Pt 2): 243-56.
6. Scarlatti F, Bauvy C, Ventruti A, et al. Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1. J Biol Chem. 2004; 279(18): 18384-91.
7. Stover TC, Sharma A, Robertson GP, Kester M. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res. 2005; 11(9): 3465-74.
8. Bourbon NA, Sandirasegarane L, Kester M. Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest. J Biol Chem. 2002; 277(5): 3286-92.
9. Chalfant CE, Szulc Z, Roddy P, et al. The structural requirements for ceramide activation of serine-threonine protein phosphatases. J Lipid Res. 2004; 45(3): 496-506.
10. Chintalapati M, Truax R, Stout R, et al. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate. J Agric Food Chem. 2009; 57(12): 5201-10.
11. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003; 9(6): 653-60.
12. Childs S, Chen JN, Garrity DM, Fishman MC. Patterning of angiogenesis in the zebrafish embryo. Development. 2002; 129(4): 973-82.
13. Yabu T, Tomimoto H, Taguchi Y, et al. Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood. 2005; 106(1): 125-34.
14. Chedotal A, Kerjan G, Moreau-Fauvarque C. The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ. 2005; 12(8): 1044-56.
15. Carmeliet P. Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet. 2003; 4(9): 710-20.
16. Munafo DB, Colombo MI. A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. Journal of cell science. 2001; 114(Pt 20): 3619-29.
17. Katsumoto M, Shingu T, Kuwashima R, et al. Biphasic effect of HMG-CoA reductase inhibitor, pitavastatin, on vascular endothelial cells and angiogenesis. Circ J. 2005; 69(12): 1547-55.
18. Sprague J, Doerry E, Douglas S, Westerfield M. The Zebrafish Information Network (ZFIN): a resource for genetic, genomic and developmental research. Nucleic Acids Res. 2001; 29(1): 87-90.
19. Svoboda KR, Linares AE, Ribera AB. Activity regulates programmed cell death of zebrafish Rohon-Beard neurons. Development. 2001; 128(18): 3511-20.
20. Svoboda KR, Vijayaraghavan S, Tanguay RL. Nicotinic receptors mediate changes in spinal motoneuron development and axonal pathfinding in embryonic zebrafish exposed to nicotine. J Neurosci. 2002; 22(24): 10731-41.
21. Johnson MD, Torri JA, Lippman ME, Dickson RB. The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res. 1993; 53(4): 873-7.
22. Heinrich M, Wickel M, Schneider-Brachert W, et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. Embo J. 1999; 18(19): 5252-63.
23. Heinrich M, Wickel M, Winoto-Morbach S, et al. Ceramide as an activator lipid of cathepsin D. Adv Exp Med Biol. 2000; 477: 305-15.
24. Emert-Sedlak L, Shangary S, Rabinovitz A, et al. Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death. Mol Cancer Ther. 2005; 4(5): 733-42.
25. Fry MJ. Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play? Breast Cancer Res. 2001; 3(5): 304-12.
26. Lavieu G, Scarlatti F, Sala G, et al. Is autophagy the key mechanism by which the sphingolipid rheostat controls the cell fate decision? Autophagy. 2007; 3(1): 45-7.
27. Biederbick A, Kern HF, Elsasser HP. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol. 1995; 66(1): 3-14.
28. Ribatti D, Vacca A, Roncali L, Dammacco F. The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. Curr Pharm Biotechnol. 2000; 1(1): 73-82.
29. Autiero M, De Smet F, Claes F, Carmeliet P. Role of neural guidance signals in blood vessel navigation. Cardiovasc Res. 2005; 65(3): 629-38.
30. Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature. 2005; 436(7048): 193-200.
31. Reimers MJ, La Du JK, Periera CB, Giovanini J, Tanguay RL. Ethanol-dependent toxicity in zebrafish is partially attenuated by antioxidants. Neurotoxicol Teratol. 2006; 28(4): 497-508.
32. Hill A, Howard CV, Strahle U, Cossins A. Neurodevelopmental defects in zebrafish (Danio rerio) at environmentally relevant dioxin (TCDD) concentrations. Toxicol Sci. 2003; 76(2): 392-9.
33. Torres-Vazquez J, Gitler AD, Fraser SD, et al. Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev Cell. 2004; 7(1): 117-23.
34. Isogai S, Lawson ND, Torrealday S, et al. Angiogenic network formation in the developing vertebrate trunk. Development. 2003; 130(21): 5281-90.
35. Garthwaite G, Bartus K, Malcolm D, et al. Signaling from blood vessels to CNS axons through nitric oxide. J Neurosci. 2006; 26(29): 7730-40.
36. Eichmann A, Le Noble F, Autiero M, Carmeliet P. Guidance of vascular and neural network formation. Curr Opin Neurobiol. 2005; 15(1): 108-15.
37. Eichmann A, Makinen T, Alitalo K. Neural guidance molecules regulate vascular remodeling and vessel navigation. Genes Dev. 2005; 19(9): 1013-21.
38. Bearden SE, Segal SS. Microvessels promote motor nerve survival and regeneration through local VEGF release following ectopic reattachment. Microcirculation. 2004; 11(8): 633-44.
39. Eisen JS, Pike SH, Debu B. The growth cones of identified motoneurons in embryonic zebrafish select appropriate pathways in the absence of specific cellular interactions. Neuron. 1989; 2(1): 1097-104.
40. Westerfield M, McMurray JV, Eisen JS. Identified motoneurons and their innervation of axial muscles in the zebrafish. J Neurosci. 1986; 6(8): 2267-77.
41. Hjorth J, Key B. Development of axon pathways in the zebrafish central nervous system. Int J Dev Biol. 2002; 46(4): 609-19.
42. Lewis KE, Eisen JS. From cells to circuits: development of the zebrafish spinal cord. Prog Neurobiol. 2003; 69(6): 419-49.
43. Thevissen K, Francois IE, Winderickx J, et al. Ceramide involvement in apoptosis and apoptotic diseases. Mini Rev Med Chem. 2006; 6(6): 699-709.
44. Lin CF, Chen CL, Lin YS. Ceramide in apoptotic signaling and anticancer therapy. Curr Med Chem. 2006; 13(14): 1609-16.
45. Siskind LJ, Kolesnick RN, Colombini M. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion. 2006; 6(3): 118-25.
46. Blazquez C, Gonzalez-Feria L, Alvarez L, et al. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res. 2004; 64(16): 5617-23.
47. Erdreich-Epstein A, Tran LB, Bowman NN, et al. Ceramide signaling in fenretinide-induced endothelial cell apoptosis. J Biol Chem. 2002; 277(51): 49531-7.
48. Vogel AM, Weinstein BM. Studying vascular development in the zebrafish. Trends Cardiovasc Med. 2000; 10(8): 352-60.
49. Isogai S, Horiguchi M, Weinstein BM. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev Biol. 2001; 230(2): 278-301.
50. Shoji W, Isogai S, Sato-Maeda M, et al. Semaphorin3a1 regulates angioblast migration and vascular development in zebrafish embryos. Development. 2003; 130(14): 3227-36.
51. Negishi M, Oinuma I, Katoh H. Plexins: axon guidance and signal transduction. Cell Mol Life Sci. 2005; 62(12): 1363-71.